Product
SHR-1906；Placebo
1 clinical trial
1 indication
Indication
Idiopathic Pulmonary FibrosisClinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single IV Infusion of SHR-1906 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-09-07